GATA3: A Multispecific But Potentially Useful Marker in Surgical Pathology A Systematic Analysis of 2500 Epithelial and Nonepithelial Tumors

GATA3 is a transcription factor important in the differentiation of breast epithelia, urothelia, and subsets of T lymphocytes. It has been suggested to be useful in the evaluation of carcinomas of mammary or urothelial origin or metastatic carcinomas, but its distribution in normal and neoplastic tissues is incompletely mapped. In this study, we examined normal developing and adult tissues and 2040 epithelial and 460 mesenchymal or neuroectodermal neoplasms for GATA3 expression to explore its diagnostic value in surgical pathology, using monoclonal antibody (clone L50-823) and Leica Bond automated immunohistochemistry. GATA3 was expressed in trophoblast, fetal and adult epidermis, adult mammary and some salivary gland and sweat gland ductal epithelia, urothelia, distal nephron in developing and adult tissues, some prostatic basal cells, and subsets of T lymphocytes. It was expressed stronger in fetal than in adult mesothelia and was absent in respiratory and gastrointestinal epithelia. In epithelial neoplasms, GATA3 was expressed in >90% of primary and metastatic ductal and lobular carcinomas of the breast, urothelial, and cutaneous basal cell carcinomas and trophoblastic and endodermal sinus tumors. In metastatic breast carcinomas, it was more sensitive than GCDFP. Among squamous cell carcinomas, the expression was highest in the skin (81%) and lower in cervical (33%), laryngeal (16%), and pulmonary tumors (12%). Common positivity was found in skin adnexal tumors (100%), mesothelioma (58%), salivary gland (43%), and pancreatic (37%) ductal carcinomas, whereas frequency of expression in adenocarcinomas of lung, stomach, colon, endometrium, ovary, and prostate was <10%. Chromophobe renal cell carcinoma was a unique renal tumor with frequent positivity (51%), whereas oncocytomas were positive in 17% of cases but other types only rarely. Among mesenchymal and neuroectodermal tumors, paragangliomas were usually positive, which sets these tumors apart from epithelial neuroendocrine tumors. Mesenchymal tumors were only sporadically positive, except epithelia of biphasic synovial sarcomas. GATA3 is a useful marker in the characterization of not only mammary and urothelial but also renal and germ cell tumors, mesotheliomas, and paragangliomas. The multiple specificities of GATA3 should be taken into account when using this marker to detect metastatic mammary or urothelial carcinomas.

[1]  Daigeler Adrien,et al.  Malignant fibrous histiocytoma—pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A pilot study , 2009, Langenbeck's Archives of Surgery.

[2]  J. D. Engel,et al.  GATA-2 and GATA-3 regulate trophoblast-specific gene expression in vivo. , 1997, Development.

[3]  Jason Wang,et al.  GATA-3 expression in male and female breast cancers: comparison of clinicopathologic parameters and prognostic relevance. , 2013, Human pathology.

[4]  K. Devriendt,et al.  Human Genome and Diseases: Review¶Transcription factor GATA3 and the human HDR syndrome , 2001, Cellular and Molecular Life Sciences CMLS.

[5]  K. Devriendt,et al.  Transcription factor GATA 3 and the human HDR syndrome , 2022 .

[6]  C. Kaufman,et al.  GATA-3: an unexpected regulator of cell lineage determination in skin. , 2003, Genes & development.

[7]  H. Friess,et al.  Aberrant Gata-3 Expression in Human Pancreatic Cancer , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[8]  Soumen Paul,et al.  GATA3 Is Selectively Expressed in the Trophectoderm of Peri-implantation Embryo and Directly Regulates Cdx2 Gene Expression* , 2009, The Journal of Biological Chemistry.

[9]  W. Paul,et al.  An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiation. , 2011, International immunology.

[10]  S. Störkel,et al.  The human chromophobe cell renal carcinoma: Its probable relation to intercalated cells of the collecting duct , 1988, Virchows Archiv. B, Cell pathology including molecular pathology.

[11]  M. Miettinen A Simple Method for Generating Multitissue Blocks Without Special Equipment , 2012, Applied immunohistochemistry & molecular morphology : AIMM.

[12]  J. Epstein,et al.  Utility of GATA3 Immunohistochemistry in Differentiating Urothelial Carcinoma From Prostate Adenocarcinoma and Squamous Cell Carcinomas of the Uterine Cervix, Anus, and Lung , 2012, The American journal of surgical pathology.

[13]  Robert J. Marinelli,et al.  Placental S100 (S100P) and GATA3: Markers for Transitional Epithelium and Urothelial Carcinoma Discovered by Complementary DNA Microarray , 2007, The American journal of surgical pathology.

[14]  Z. Werb,et al.  GATA3 in development and cancer differentiation: Cells GATA have it! , 2010, Journal of cellular physiology.

[15]  D. Krahl,et al.  Expression pattern of GATA‐3 in embryonic and fetal human skin suggests a role in epidermal and follicular morphogenesis , 2010, Journal of cutaneous pathology.

[16]  L. Truong,et al.  Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related renal neoplasms , 2005, Modern Pathology.

[17]  P. Oettgen,et al.  Critical Role for GATA3 in Mediating Tie2 Expression and Function in Large Vessel Endothelial Cells* , 2009, The Journal of Biological Chemistry.

[18]  D. Nonaka,et al.  A Study of Gata3 and Phox2b Expression in Tumors of the Autonomic Nervous System , 2013, The American journal of surgical pathology.

[19]  J. Higgins,et al.  Expression of the Urothelial Differentiation Markers GATA3 and Placental S100 (S100P) in Female Genital Tract Transitional Cell Proliferations , 2009, The American journal of surgical pathology.

[20]  W. Linehan,et al.  Renal Tumors in the Birt-Hogg-Dubé Syndrome , 2002, The American journal of surgical pathology.

[21]  T. Ulbright Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues , 2005, Modern Pathology.

[22]  G. Blobel,et al.  GATA Transcription Factors and Cancer. , 2010, Genes & cancer.

[23]  Marie-Liesse Asselin-Labat,et al.  Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation , 2007, Nature Cell Biology.

[24]  Qi Yang,et al.  GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor. , 2012, Human pathology.

[25]  Hans Clevers,et al.  Reprints Available Directly from the Publisher Photocopying Permitted by License Only Expression of Gata-3 during Lymphocyte Differentiation and Mouse Embryogenesis , 2022 .

[26]  Marc K Halushka,et al.  GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas. , 2013, Human pathology.

[27]  S. Störkel,et al.  Intercalated cells as a probable source for the development of renal oncocytoma , 1988, Virchows Archiv. B, Cell pathology including molecular pathology.

[28]  J. Eble,et al.  Morphologic features of renal oncocytoma: a light and electron microscopic study. , 1984, Human pathology.

[29]  J. McKenney,et al.  Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung. , 2012, Archives of pathology & laboratory medicine.

[30]  J. Rossant,et al.  Gata3 regulates trophoblast development downstream of Tead4 and in parallel to Cdx2 , 2010, Development.

[31]  M. Wilkerson,et al.  Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas. , 2012, American journal of clinical pathology.

[32]  Steve Horvath,et al.  Higher levels of GATA3 predict better survival in women with breast cancer. , 2010, Human pathology.